Почетна › Рак јајника › Вирџинија › Arlington
Kliničke studije za Рак јајника u gradu Arlington, VA
47 studija za Рак јајника traži učesnike na lokacijama u gradu Arlington i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
- NEXT Virginia, Fairfax · 11 ми удаљено
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Тражи се учесникФаза 2
- Inova Fairfax Hospital, Falls Church · 4 ми удаљено
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Тражи се учесникФаза 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · 11 ми удаљено
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Тражи се учесникФаза 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · 11 ми удаљено
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Тражи се учесник
- Inova Fairfax Hospital, Falls Church · 4 ми удаљено
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
- Inova Fair Oaks Hospital, Fairfax · 11 ми удаљено
The Vanguard Study: Testing a New Way to Screen for Cancer
Тражи се учесникЗдраве особе су добродошле
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
- Inova Fair Oaks Hospital, Fairfax · 11 ми удаљено
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Тражи се учесникФаза 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Тражи се учесникФаза 1
- Inova Schar Cancer Institute, Falls Church · 4 ми удаљено
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Clinical Study Site, Fairfax · 11 ми удаљено
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Тражи се учесникФаза 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Тражи се учесникФаза 1
- Inova Schar Cancer Institute, Falls Church · 4 ми удаљено
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Тражи се учесникФаза 1/2
- NEXT Oncology, Fairfax · 11 ми удаљено
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Тражи се учесникФаза 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · 11 ми удаљено
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Тражи се учесникФаза 1
- Next Virginia /ID# 278607, Fairfax · 11 ми удаљено
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Clinical Trial Site, Fairfax · 11 ми удаљено
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Тражи се учесникФаза 1
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- NEXT, Fairfax · 11 ми удаљено
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Тражи се учесникФаза 1/2
- Research Site, Fairfax · 11 ми удаљено
A Study of PHST001 in Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology - Virginia, Fairfax · 11 ми удаљено
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Тражи се учесникФаза 2
- Next Virginia /ID# 279684, Fairfax · 11 ми удаљено
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Тражи се учесникФаза 1
- Site 04, Fairfax · 11 ми удаљено
Study of AVZO-021 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 ми удаљено
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Тражи се учесникФаза 1
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Тражи се учесникФаза 2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Тражи се учесникФаза 1
- NEXT Oncology, Fairfax · 11 ми удаљено
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Тражи се учесникФаза 1
- Normunity Investigational Site, Fairfax · 11 ми удаљено
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Тражи се учесникФаза 2
- 522, Fairfax · 11 ми удаљено
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 ми удаљено
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Тражи се учесникФаза 1
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Тражи се учесникФаза 3
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Тражи се учесникФаза 1
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, Fairfax · 11 ми удаљено
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Тражи се учесникФаза 1
- Dren Investigational Site, Fairfax · 11 ми удаљено
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Studije za Рак јајника u drugim gradovima
- Houston, TX90 студија
- New York City, NY75 студија
- Boston, MA62 студија
- Los Angeles, CA53 студија
- Nashville, TN50 студија
- Philadelphia, PA47 студија
- Columbus, OH39 студија
- St. Louis, MO37 студија
- Chicago, IL36 студија
- San Antonio, TX33 студија
- Pittsburgh, PA32 студија
- Dallas, TX31 студија
Ostale studije u gradu Arlington
- Немалоклетни карцином плућа111 студија
- Колоректални карцином54 студија
- Метастатски карцином52 студија
- Рак (све врсте)52 студија
- Рак дојке50 студија
- Рак плућа42 студија
- Карцином ендометријума41 студија
- Рак панкреаса33 студија
- Плоскоклеточни карцином главе и врата29 студија
- Sitnoćelijski rak pluća22 студија
- Trostruko negativni rak dojke21 студија
- Рак желуца21 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.